Resistance Training Has an Effect on Lowering Insulin Resistance Based on HOMA IR Examination in Poly Cystic Ovarian Syndrome (PCOS) Patients: Meta-Analysis
Abstract
Abstract: Poly Cystic Ovarian Syndrome (PCOS) is a complex endocrine disorder that affects women of reproductive age. Insulin resistance, obesity, and hormonal imbalances are the main characteristics of this condition. Physical exercise, including weight training or resistance training , is suspected to be effective in lowering insulin resistance, but direct comparisons based on the results of the HOMA IR examination have not been carried out systematically. This meta-analysis aimed to evaluate the effectiveness of weight training in lowering insulin resistance based on the results of the HOMA IR examination in PCOS patients. Four clinical studies that met the inclusion criteria and included 87 women diagnosed with PCOS and 93 women without PCOS were analyzed for their insulin resistance conditions. Insulin resistance check parameters using the HOMA IR test. Statistical analysis using a fixed effect model with a paired t test. Overall, resistance training interventions showed a negative effect on the difference in HOMA-IR between pre-test and post-test. The mean HOMA-IR score after the intervention was lower compared to the pre-intervention score. This suggests that resistance training can lower insulin resistance in PCOS patients. Resistance training can reduce insulin resistance in PCOS patients as measured by HOMA-IR examination. However, variations in results between studies suggest that the effects of resistance training on insulin resistance are not entirely uniform, depending on factors such as exercise intensity, duration, and characteristics of study participants.
Keywords
Full Text:
PDFReferences
Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obesity Facts. 2009;2(1):26–35. doi:10.1159/000194971. (https://pmc.ncbi.nlm.nih.gov/articles/PMC6444522/)
Teede, H. J., Misso, M., Costello, M. F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602-1618. (https://pmc.ncbi.nlm.nih.gov/articles/PMC6939856/)
Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2021;00:1–11. doi:10.1111/cen.14421. (https://onlinelibrary.wiley.com/doi/10.1111/cen.14421)
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. doi:10.1093/humrep/deh098. (https://academic.oup.com/humrep/article-abstract/19/1/41/690226?redirectedFrom=fulltext&login=false)
Essah PA, Nestler JE. Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril. 2006;86(Suppl 1):S18–S19. doi:10.1016/j.fertnstert.2006.04.013. (https://www.fertstert.org/article/S0015-0282(06)01021-1/pdf)
Matthews DR, Hosker JR, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi:10.1007/BF00280774. (https://pubmed.ncbi.nlm.nih.gov/3899825/)
Harrison CL, Stepto NK, Hutchison SK, Teede HJ. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;76(3):351–357. doi:10.1111/j.1365-2265.2011.04160. (https://pubmed.ncbi.nlm.nih.gov/21711376/)
Almenning I, Rieber-Mohn A, Lundgren KM, et al. Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: A pilot study. PLoS One. 2015;10(9):e0138793. doi:10.1371/journal.pone.0138793. (https://pubmed.ncbi.nlm.nih.gov/26406234/)
Kogure GS, Silva RC, Miranda-Furtado CL, Ribeiro VB, Pedroso DCC, Melo AS, Ferriani RA, Reis RM. Hyperandrogenism enhances muscle strength after progressive resistance training, independent of body composition, in women with polycystic ovary syndrome. J Strength Cond Res. 2018;32(9):2642-2651. doi:10.1519/JSC.0000000000002821. (https://journals.lww.com/nsca-jscr/fulltext/2018/09000/hyperandrogenism_enhances_muscle_strength_after.28.aspx)
Ribeiro VB, Kogure GS, Reis RM, Gastaldi AC, de Araújo JE, Mazon JH, Borghi A, Souza HCD. Polycystic ovary syndrome presents higher sympathetic cardiac autonomic modulation that is not altered by strength training. Int J Exerc Sci. 2016;9(5):554-566. (https://pmc.ncbi.nlm.nih.gov/articles/PMC5154718/)
Vizza L, Smith CA, Swaraj S, Agho K, Cheema BS. The feasibility of progressive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial. BMC Sports Sci Med Rehabil. 2016;8:14. doi:10.1186/s13102-016-0039-8. (https://pmc.ncbi.nlm.nih.gov/articles/PMC4865007/)
Hawley JA. Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance. Diabetes Metab Res Rev. 2004;20(5):383-393. doi:10.1002/dmrr.505. (https://onlinelibrary.wiley.com/doi/10.1002/dmrr.505)
Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001;286(10):1218-1227. doi:10.1001/jama.286.10.1218. (https://jamanetwork.com/journals/jama/article-abstract/194184)
Houmard JA, Tanner CJ, Slentz CA, Duscha BD, McCartney JS, Kraus WE. Effect of the volume and intensity of exercise training on insulin sensitivity. J Appl Physiol. 2004;96(1):101-106. doi:10.1152/japplphysiol.00707.2003. (https://journals.physiology.org/doi/full/10.1152/japplphysiol.00707.2003?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org)
DOI (PDF): https://doi.org/10.30596/bf.v10i3.24468.g13715
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

